Matthew Hamilton Rosenberg’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $102K | Hold |
6,108
| – | – | 0.02% | 324 |
|
|
2025
Q1 | $93.9K | Hold |
6,108
| – | – | 0.02% | 326 |
|
|
2024
Q4 | $135K | Hold |
6,108
| – | – | 0.04% | 256 |
|
|
2024
Q3 | $110K | Hold |
6,108
| – | – | 0.03% | 306 |
|
|
2024
Q2 | $99.8K | Hold |
6,108
| – | – | 0.03% | 296 |
|
|
2024
Q1 | $85K | Hold |
6,108
| – | – | 0.02% | 339 |
|
|
2023
Q4 | $63.8K | Hold |
6,108
| – | – | 0.02% | 389 |
|
|
2023
Q3 | $62.3K | Hold |
6,108
| – | – | 0.02% | 384 |
|
|
2023
Q2 | $46K | Buy |
6,108
+1
| +0% | +$8 | 0.02% | 448 |
|
|
2023
Q1 | $54K | Hold |
6,107
| – | – | 0.02% | 447 |
|
|
2022
Q4 | $55.7K | Hold |
6,107
| – | – | 0.02% | 431 |
|
|
2022
Q3 | $49K | Hold |
6,107
| – | – | 0.02% | 442 |
|
|
2022
Q2 | $48K | Buy |
6,107
+1,107
| +22% | +$8.7K | 0.02% | 470 |
|
|
2022
Q1 | $47K | Hold |
5,000
| – | – | 0.02% | 470 |
|
|
2021
Q4 | $40K | Hold |
5,000
| – | – | 0.01% | 452 |
|
|
2021
Q3 | $49K | Hold |
5,000
| – | – | 0.02% | 397 |
|
|
2021
Q2 | $50K | Hold |
5,000
| – | – | 0.03% | 357 |
|
|
2021
Q1 | $58K | Hold |
5,000
| – | – | 0.03% | 330 |
|
|
2020
Q4 | $48K | Hold |
5,000
| – | – | 0.03% | 334 |
|
|
2020
Q3 | $45K | Hold |
5,000
| – | – | 0.03% | 320 |
|
|
2020
Q2 | $62K | Hold |
5,000
| – | – | 0.05% | 276 |
|
|
2020
Q1 | $45K | Buy |
+5,000
| New | +$45K | 0.04% | 274 |
|